Insights on type 2 Diabetes mellitus management from Ethiopian perspective and evaluation of the impact of a pharmaceutical care on clinical outcome and medication adherence in type 2 Diabetes mellitus patients: A randomized controlled study.

PCT2DMEP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202109562160747

Enrollment

200

Registered

2021-09-15

Start date

2020-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

Pharmaceutical care services

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: If they were aged 18 years or older Treated at WUNEMMCS Hospital and diagnosed with type 2 diabetes at least 6 months previously, Took at least 1 prescribed medication for diabetes Had regular visits for last 6 months with or without concomitant Willingness to participate

Exclusion criteria

Exclusion criteria: If they were missing visits in the previous six months Not willing to participate Participated in DM educational programs in the last 3 months Mentally incapable to participate Other types of diabetes Pregnancy Comorbidity of cancer, organ failure, or other severe diseases Unable to communicate and understand Amharic language

Design outcomes

Primary

Measure	Time frame
The primary outcome measure was change in fasting blood glucose (FBG)	—

Secondary

Measure	Time frame
All other data collected, including blood pressure, serum lipid values (LDL-C, HDL-C, TC and TG), liver function tests (AST, ALT, ALP),kidney function parameters ( BUN, SrCr, eGFR) and medication adherence	—

Countries

Ethiopia

Contacts

Public ContactABDIKAREM ABDI

Department of Clinical Pharmacy

daud87@hotmail.com+905449694997

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026